21 donorss.
| Date | Contributor | Type | Employer | Occupation | Amount |
|---|---|---|---|---|---|
| 2026-01-23 | Jeffrey Poulton | IND | Alnylam Pharmaceuticals, Inc. | Executive Officer | $208.33 |
| 2026-01-23 | Yvonne Greenstreet | IND | Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | $208.33 |
| 2026-01-23 | Melissa McLaughlin | IND | Alnylam Pharmaceuticals, Inc. | Chief Human Resources Officer | $208.33 |
| 2026-01-23 | Lubomir Nechev | IND | Alnylam Pharmaceuricals, Inc. | Chief CMC Officer | $208.33 |
| 2026-01-23 | Michael Tirozzi | IND | Alnylam Pharmaceuticals, Inc. | CIO | $208.33 |
| 2026-01-23 | Pushkal Garg | IND | Alnylam Pharmaceuticals, Inc. | Chief Medical Officer | $208.33 |
| 2026-01-23 | Tolga Tanguler | IND | Alnylam Pharmaceuticals, Inc. | Chief Commercial Officer | $208.33 |
| 2026-01-23 | Timothy Maines | IND | Alnylam Pharmaceuticals, Inc. | SVP Global Quality Assurance | $192.30 |
| 2026-01-23 | Deirdre Parsons | IND | Alnylam Pharmaceuticals, Inc. | Senior Director, Global Public Policy | $125.00 |
| 2026-01-23 | Christine Akinc | IND | Alnylam Pharmaceuticals, Inc. | General Manager, Givosiran | $104.16 |
| 2026-01-23 | Kevin Fitzgerald | IND | Alnylam Pharmaceuticals, Inc. | CSO & EVP, Research & Early Dev. | $104.16 |
| 2026-01-23 | Norton Fortuna | IND | Alnylam Pharmaceuticals, Inc. | Senior Vice President | $104.16 |
| 2026-01-23 | Curtis Rhyne | IND | Alnylam Pharmaceuticals, Inc. | Director of Government Relations | $104.16 |
| 2026-01-23 | Cory Siddons | IND | Alnylam Pharmaceuticals, Inc. | VP, Supply Chain | $104.16 |
| 2026-01-09 | Melissa McLaughlin | IND | Alnylam Pharmaceuticals, Inc. | Chief Human Resources Officer | $208.33 |
| 2026-01-09 | Michael Tirozzi | IND | Alnylam Pharmaceuticals, Inc. | CIO | $208.33 |
| 2026-01-09 | Pushkal Garg | IND | Alnylam Pharmaceuticals, Inc. | Chief Medical Officer | $208.33 |
| 2026-01-09 | Tolga Tanguler | IND | Alnylam Pharmaceuticals, Inc. | Chief Commercial Officer | $208.33 |
| 2026-01-09 | Yvonne Greenstreet | IND | Alnylam Pharmaceuticals, Inc. | Chief Executive Officer | $208.33 |
| 2026-01-09 | Lubomir Nechev | IND | Alnylam Pharmaceuricals, Inc. | Chief CMC Officer | $208.33 |
| 2026-01-09 | Jeffrey Poulton | IND | Alnylam Pharmaceuticals, Inc. | Executive Officer | $208.33 |